TNF alpha inhibits Schwann cell proliferation, connexin46 expression, and gap junctional communication.
Schwann cell responses to nerve injury are stimulated, in part, by inflammatory cytokines. This study compares changes in the phenotype of cultured Schwann cells after exposure to the cytokine tumor necrosis factor (TNF)-alpha or the mitogen neu differentiation factor (NDF)-beta. TNF alpha inhibited proliferation in a dose-dependent manner without altering Schwann cell survival. TNF alpha also reduced both gap junctional conductance and Lucifer yellow dye coupling between Schwann cells. Moreover, both Po and glial fibrillary acidic protein (GFAP) immunoreactivity were reduced. By contrast, NDF beta initially had little effect on cell division although it reduced junctional coupling within 8 h. However, by 48 h, NDF beta stimulated proliferation with a concomitant increase in coupling. Dividing Schwann cells (BrdU+) were preferentially dye coupled compared to nondividing cells, indicating an association between proliferation and coupling. Moreover, cultured Schwann cells expressed connexin46 mRNA and protein, and changes in the levels of the protein correlated with the degree of proliferation and coupling. The data thus provide evidence for cytokine-induced modulation of Schwann cell antigenic phenotype, proliferation, and gap junction properties. These observations suggest that enhanced gap junctional communication among Schwann cells after nerve injury could help to coordinate cellular responses to the injury, and that TNF alpha may be a signal which terminates proliferation as well as junctional communication.
Chandross
K J
KJ
Department of Neuroscience, Albert Einstein College of Medicine, Bronx, New York 10461, USA.
Spray
D C
DC
Cohen
R I
RI
Kumar
N M
NM
Kremer
M
M
Dermietzel
R
R
Kessler
J A
JA
D000818:Animals; D000831:Animals, Newborn; D002450:Cell Communication / Q000187:drug effects*; D002455:Cell Division / Q000187:drug effects; D002478:Cells, Cultured; D017630:Connexins / Q000096:biosynthesis* / Q000235:genetics; D017629:Gap Junctions / Q000187:drug effects*; D005786:Gene Expression Regulation / Q000187:drug effects*; D005904:Glial Fibrillary Acidic Protein / Q000096:biosynthesis / Q000235:genetics; D018993:Myelin P0 Protein / Q000096:biosynthesis / Q000235:genetics; D009419:Nerve Tissue Proteins / Q000096:biosynthesis / Q000235:genetics; D016133:Polymerase Chain Reaction; D012333:RNA, Messenger / Q000096:biosynthesis / Q000235:genetics; D051381:Rats; D012583:Schwann Cells / Q000166:cytology / Q000187:drug effects*; D012584:Sciatic Nerve / Q000166:cytology; D014409:Tumor Necrosis Factor-alpha / Q000494:pharmacology*
D017630:Connexins; D005904:Glial Fibrillary Acidic Protein; D018993:Myelin P0 Protein; D009419:Nerve Tissue Proteins; D012333:RNA, Messenger; D014409:Tumor Necrosis Factor-alpha; C082917:GJA3 protein, human